The study performed by Cho et al. revealed that RUNX1 was the most frequently mutated gene in MDS transformation to AML and suggested that mutations that interested the RUNX1 gene may appear later in the process of tumorigenesis and may be associated with a poor prognosis due to evolution to a more aggressive disorder [39]. Here, RUNX1 is linked to myelodysplastic syndrome.